RT Dose Main Risk for Radiation-Induced Optic Neuropathy

Share this content:
RT Dose Main Risk for Radiation-Induced Optic Neuropathy
RT Dose Main Risk for Radiation-Induced Optic Neuropathy

MONDAY, Feb. 13, 2017 (HealthDay News) -- The main risk factor for developing radiation-induced optic neuropathy (RION) is radiation dose, with no indication of other significant risk factors, according to a study published online Feb. 9 in Clinical & Experimental Ophthalmology.

Ian Ferguson, from Washington University in St. Louis, and colleagues conducted a retrospective case-control study at a university hospital tertiary care center. They identified 14 cases meeting criteria for a diagnosis of RION by neuro-ophthalmologic exam. Cases were matched with 31 controls without RION based upon maximum radiation dose to the optic apparatus. The authors examined patient characteristics and treatment parameters for attributes predisposing to RION in univariate analysis.

The researchers found that there were no significant associations for alternative risk factors after controlling for radiation dosage.

"These results support the literature suggesting that the primary risk factor for developing RION is radiation dosage and that additional, patient- and tumor-related risk factors may play only a minor role," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »